Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept study

Abstract Introduction Chronic inflammatory demyelinating polyneuropathy (CIDP) is one of the most common immune neuropathies leading to severe impairments in daily life. Current treatment options include intravenous immunoglobulins (IVIG), which are administered at intervals of 4–12 weeks. Determina...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Lars Masanneck, Jan Voth, Niklas Huntemann, Menekse Öztürk, Christina B. Schroeter, Tobias Ruck, Sven G. Meuth, Marc Pawlitzki
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-08-01
Serie:	Neurological Research and Practice
Soggetti:	Clinical trial Digital health technology CIDP End-of-dose Smartwatch
Accesso online:	https://doi.org/10.1186/s42466-023-00267-3
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!